CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- 4 Grant or award Chief Legal Officer acquired 165,938 shares (grant or award)
- 4 Grant or award President & CEO acquired 410,625 shares (grant or award)
- 144 Insider Sale of Securities
- 8-K Event Acquisition or sale completed
- 4 Open-market sale Chief R&D Officer sold 7,785 shares at $1.01 ($7,863)
- 4 Open-market sale Chief Legal Officer sold 6,407 shares at $1.01 ($6,471)
- 4 Open-market sale President & CEO sold 16,278 shares at $1.01 ($16,441)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market sale Chief R&D Officer sold 6,866 shares at $1.28 ($8,788)
- 4 Open-market sale Chief Legal Officer sold 5,651 shares at $1.28 ($7,233)
- 4 Open-market sale President & CEO sold 14,881 shares at $1.28 ($19,048)
Page 10 of 100 · 1,982 filings